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Dicoumarin Synthesized 
The toxic factor of sweet clover disease 
Loyal Payne, D.V.M.* 
T HE study of coumarin derivatives be-gan with the identification of the 
causative agent in sweet clover respon-
sible for the hemorrhagic disease of cattle 
now called "sweet clover disease." The 
investigation of this disease and the isola-
tion of the etiological factor has estab-
lished both the chemical and physiological 
properties of dicoumarin. 
"Sweet clover poisoning" was first re-
ported in the literature as early as 1888 
when European workers reported a dis-
ease in cattle which were being fed sweet 
clover, but they did not recognize the 
sweet clover as the cause of the disease. 
The disease was then considered to be of 
bacterial origin. In 1912, two Frenchmen, 
Gain and Brocq-Roussei, noted deaths in 
cattle which had been fed sweet clover, 
but again they did not correlate the sweet 
clover and the death of the animals. 
In 1923, a Canadian named Schofield1 
reported the discovery of a new specific 
disease in cattle resulting from the feed-
ing of spoiled sweet clover. Practically 
simultaneously, Roderick·l at North Da-
kota State College began investigating the 
same disease. The work of both of these 
investigators was concerned mainly with 
the diagnosis, treatment, and prevention 
of the disease. They recognized sweet 
clover as the etiological agent, but did not 
know how it acted. Roderick3 did consid-
erable work on the gross and microscopic 
pathology, together with a study of the 
blood changes, in an attempt to find the 
cause. 
Roderick and Schalk\ in the North Da-
kota Experiment Station Bulletin 250 
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(July 1931) described the disease quite 
well. This bulletin considered the diagno-
sis, etiology, symptoms, time required to 
produce the disease, and the hematology. 
They also thoroughly reviewed the early 
experimental work. 
Sweet clover disease was first named 
"sweet clover poisoning" by Schofield1 in 
1921. He definitely showed that spoiled 
sweet clover could cause fatal hemorr-
hage if fed to cattle or experimental ani-
mals, but that good quality sweet clover 
did not produce the condition and was safe 
if properly fed. He also correlated the 
presence of a mold (usually located with-
in the clover stalk) with the occurrence 
of the disease. Therefore, he concluded 
that either the mold itself, or a decom-
position product, caused the disease al-
though he did not prove the correctness of 
his view. 
Noninfectious 
Roderick and Schalk5 in 1926 showed 
the disease was not transmitted from one 
animal to another, even by direct blood 
transfusion, and therefore was not infec-
tious. 
The earliest symptom of the disease was 
a failure of the blood to clot normally. 
All of these investigators found that in 
experimental animals fed spoiled sweet 
clover, the blood clotting time would in-
crease from a normal of fifteen to thirty 
minutes to three to four hours, or often 
fail to clot at all. Non-crepitating subcu-
taneous swellings appeared which were 
round and firm. The mucous membranes 
appeared pale. Death from hemorrhage 
often followed an operation such as de-
horning or castration. The time required 
for death to occur in the experimental 
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animals ranged from twenty-five to fifty-
three days after being placed on sweet clo-
ver rations. Death occurred spontane-
ously in most of these cases. Young ani-
mals seemed to be more susceptible than 
older ones. 
The hematology of the diseased animals 
was studied. Red blood cell counts made 
in the later stages of the disease showed a 
marked decrease in number. This was 
thought to be due to the internal hemor-
rhage. The hemoglobin was correspond-
ingly lowered. There was a decrease in the 
blood platelets but this was not considered 
significant. The leucocyte count was not 
of pathological significance. Determination 
of the calcium content of the blood from 
these animals did not show sufficient vari-
ation from the normal to be considered 
significant in the slowed clotting time. It 
was thought for a while that the condition 
might be some form of a deficiency dis-
ease. However, it was shown that cattle 
contracted the disease even if an adequate 
ration was fed along with the sweet clo-
ver. The prothrombin content of the blood 
showed a decrease proportional to the 
coagulation time. This was one of the 
most important changes noted. 
Early Investigations 
Schofield, through reference to an ar-
ticle in "Manual of Poisonous Plants" by 
PammelG, and also Roderick and Schalk4, 
recognized the coumarin content of sweet 
clover as a potential factor in the disease. 
These investigators independently carried 
out experiments in which coumarin was 
fed to rabbits in considerable amounts. 
The animals died but did not show any 
hemorrhagic lesions, so it was thought 
that if coumarin was responsible it must 
be a decomposition product that produced 
the lesions. This was as near as they came 
to discovering the actual cause of the dis-
ease. 
Coumarin (C"H(;OJ occurs as colorless 
crystals, with a characteristic pleasant, 
fragrant odor and a bitter, aromatic, burn-
ing taste. It is the constituent responsible 
for the fragrant odor of new mown clover. 
Coumarin is often used as a flavoring 
agent for various food products and me-
dicinal preparations. 
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In a short time following the first re-
ports of this new disease, its occurrence 
was being recognized in many states. The 
outstanding feature always noted was a 
failure of the blood to clot. Blood coagu-
lation is primarily a process involving the 
plasma. The process of coagulation is 
complex and the exact details are still 
somewhat uncertain. 
It is generally accepted that plasma con-
tains all of the essential elements neces-
sary for complete coagulation, and that 
the combination of the blood protein, 
fibrinogen, and thrombin produces fibrin 
which is the essential element of the clot. 
Fibrin is an insoluble protein not found 
in normal blood. It is the manner in which 
thrombin is formed that is debated. 
Morawitz Theory 
As explained by the Morawitz theory, 
thrombin is formed by the reaction of 
thrombokinase (cephalin) and calcium 
with prothrombin, normally present in 
the plasma, whereby the prothrombin is 
converted to thrombin. The thrombin in 
turn unites with the fibrinogen to form 
fibrin. This theory suggests that calcium 
is not essential for the final stages of clot-
ting, but that its presence is necessary 
primarily for the activation of prothrom-
bin. 
Howell's theory assumes that prothrom-
bin can be changed to thrombin by cal-
cium alone, but this reaction is normally 
prevented by a substance, heparin, in the 
blood, which he designates as an anti-
prothrombin. When thrombokinase de-
velops in sufficient amount, it neutralizes 
the heparin (antiprothrombin) and thus 
prothrombin is free to react with calcium 
to produce thrombin. Thrombin plus 
fibrinogen then yields the fibrin. 
Data Accumulated 
Between 1920 and 1933, data on sweet 
clover disease rapidly accumulated. Most 
of the work up to this time had been done 
by Schofield in Canada and Roderick in 
North Dakota. The most conclusive thing 
they discovered was the altered prothrom-
bip. content of the blood. This was also 
confirmed by several other workers. In 
(Continued on page 202) 
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1933, investigations were undertaken at 
the University of Wisconsin when Dr. 
R. A. Brink of the Genetics Department 
initiated some attempts to select a non-
bitter strain of sweet clover. He suggested 
the problem to Dr. H. A. Campbell, Dr. 
K. P. Link and other biochemists there. 
This started the second phase of the in-
vestigation of sweet clover poisoning, 
which resulted in the discovery and isola-
tion of the "hemorrhagic agent." It was 
this work that established Link with 
Schofield and Roderick as the pioneers in 
this field. 
In 1937, Roberts and Link' published a 
report dealing with the determination of 
coumarin, melilotic acid and coumaric 
acid in sweet clover. In 1940, Campbell, 
Roberts, Smith, and Linkk published the 
results of their research dealing with the 
preparation of what they called the 
"hemorrhagic concentrate" found in sweet 
clover. 
Two problems confronted these work-
ers. First, there were no chemical criteria 
available to establish the presence of such 
a factor, and second, bio-assay offered the 
only means of testing the concentrates 
and extracts which they obtained, so they 
used a method in which the prothrombin 
level of rabbit plasma was taken as the 
standard.H In 1936-37 they developed a 
method .for the preparation of the active 
concentrate. After several attempts they 
were able to obtain it in some quantity. 
There followed a long and tedious series 
of experiments through which, by the pro-
cess of elimination, they were able to de-
termine its chemical structure. 
At the same time, work by other inves-
tigators was also being done upon the ex-
traction and utilization of heparin as an 
anticoagulant, and Link and associates 
came to a realization of the similar effects 
produced by these two substances. 
In 1940 Campbell and Link10 reported 
the isolation and the crystallization of the 
"hemorrhagic agent." Dr. Campbell then 
moved to another post and Stahmann, 
Heubner, and Linkl1 carried on further 
research. Soon after the isolation of the 
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"hemorrhagic agent," the identification 
and the synthesis of the substance was ac-
complished. Up until then, they had al-
ways referred to the toxic factor as the 
"hemorrhagic agent" for want of a better 
name. Finally, it was shown that the toxic 
factor of spoiled sweet clover was chemi-
cally 3,3' methylene-bis (4-hydroxycou-
marin). Studies in experimental feeding 
proved that the new substance synthesized 
by these workers was identical with that 
found in the spoiled sweet clover. It was 
also concluded that this new substance 
was not identical with any of the sixty or 
more naturally occurring coumarins pre-
viously reported, but was a newly found 
form which caused the disease. 
Allen, Barker, and Waugh12 of the Mayo 
Foundation suggested this new substance 
be called "dicoumarin," as it is a family 
name and because the 3,3' methylene-bis 
(4-hydroxycoumarin) is a "di-" coumarin. 
The Wisconsin Alumni Research Founda-
tion, which controls the distribution of this 
product, gave it the trade name "Dicou-
marol." Either name, dicoumarin or di-
coumarol, is now acceptable. 
Clinical Application 
Recently, extensive investigations have 
been carried on to determine the possible 
rational clinical applications of dicoumarin 
as an anticoagulant. Work on the toxicity 
of dicoumarin on mice, rats, and guinea 
pigs was carried on by Rose et ap:J of the 
Eli Lilly Research Laboratories. In 1942, 
Stats and Bullowa 14 reported the effects 
of a single dose of dicoumarin upon blood 
coagulation in man. The dosage varied 
from 1 to 12 mg. per Kilo of body weight, 
the average dose used being 8 mg. per 
Kilo, given orally. They studied the pro-
thrombin level and coagulation time be-
fore the administration and for several 
days following administration. A prolong-
ation of coagulation time was reported in 
about six days beginning between twenty-
four and forty-eight hours after the ad-
ministration of the drug. 
The human dosage as determined by 
Barker et al12 of the Mayo Foundation 
was 300 mg. orally the first day, 200 mg. 
the second day, and 200 mg. per day there-
after, for five to thirty-three days. Daily 
The Veterinary Student 
determinations of the prothrombin and 
coagulation times were made before, dur-
ing, and after administration. 
Butsch and StewartUi suggested 300 mg. 
on two successive days as the basic dosage 
for prophylactic oral use. They reported 
the physiologic effect from this dosage 
should last about four weeks. 
The Abbott Laboratories, Mayo Foun-
dation, and Columbia University have 
been leaders in the investigation of di-
coumarin and its clinical application. 
Either oral or intravenous methods of ad-
ministration may be used. Latent periods 
of from twenty-four to forty-eight hours 
are always observed in oral administra-
tion. The advantages of administration di-
rectly into the circulatory system are the 
control of absorption and a more exact 
blood concentration. 
Clinical case reports following the use 
of dicoumarin are favorable in such con-
ditions as pulmonary thrombosis, throm-
bophlebitis, and postoperative embolism. 
Research by Allen, Barker, and 
Waugh12 indicates that heparin and di-
coumarin can be successfully used to-
gether, giving a quick and more prolonged 
action. Vitamin K apparently has no effect 
on the lowered prothrombin level result-
ing from the administration of dicoumarin. 
Doubtless there will be many case re-
ports published in the near future dealing 
with the effects of this new therapeutic 
product. Present indications are that it 
has great clinical possibilities. 
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(Ccmtinued from page 161) 
hog cholera. Foot and mouth disease, 
brucellosis, and tuberculosis cause the 
greatest losses at the present time in the 
cattle industry. With the foot and mouth 
disease vaccine, which is beginning to be 
manufactured in Chile, it is hoped that 
this disease can soon be eradicated. The 
vaccine was developed by Waldmann and 
Koebe in 1938, and its efficiency was partly 
proved in Europe before World War II. 
Brucellosis will also be reduced to some 
extent when calfhood vaccination has been 
more completely developed. Tuberculosis 
as well as infectious abortion has been 
eliminated at this time from all purebred 
stock by semi-annual testing and the elim-
ination of the positive reactors from the 
herdbooks. 
We feel justified in thinking that our 
veterinary medical school is one of the 
best in South America. Its influence has 
extended all along the Pacific coast and 
in these countries there are veterinarians 
who acquired their degrees in Chile and 
at the present time occupy important posi-
tions in the departments of hygiene and 
animal production. 
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